SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2022 quarter moved down -31.40% to Rs. 149.82 millions as compared to Rs. 218.41 millions during the year ago period.The Net Loss for the quarter ended March 2022 is Rs. -10.15 millions as compared to Net Profit of Rs. 26.37 millions of corresponding quarter ended March 2021The Operating Profit of the company witnessed a decrease to 7.45 millions from 45.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 149.82 218.41 -31.40 851.40 712.18 19.55 851.40 712.18 19.55
Other Income 12.68 3.08 311.69 21.02 7.49 180.64 21.02 7.49 180.64
PBIDT 7.45 45.10 -83.48 135.94 110.47 23.06 135.94 110.47 23.06
Interest 1.68 3.75 -55.20 7.94 7.42 7.01 7.94 7.42 7.01
PBDT 3.86 41.35 -90.67 106.44 103.05 3.29 106.44 103.05 3.29
Depreciation 14.01 14.98 -6.48 54.93 44.78 22.67 54.93 44.78 22.67
PBT -10.15 26.37 -138.49 51.51 58.27 -11.60 51.51 58.27 -11.60
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -10.15 26.37 -138.49 51.51 58.27 -11.60 51.51 58.27 -11.60
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 4.97 20.65 -75.92 15.97 15.51 2.93 15.97 15.51 2.93

Bafna Pharma Share Price

133.00 0.95 (0.72%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×